Home › Funds › Royce & Associates › INDV
Royce & Associates position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)9.90K sh
Reported value held$301.75K
Portfolio Weight0.00%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 246.52K | $5.94M | New |
| Q4 2025 | 307.86K | $11.05M | Add |
| Q1 2026 | 9.90K | $301.75K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INDV
- BlackRock Inc 18.71M sh · $767.65M · Q2 2026
- Vanguard Group 5.47M sh · $196.40M · Q4 2025
- Morgan Stanley 3.40M sh · $139.33M · Q2 2026
- Franklin Resources 3.32M sh · $136.07M · Q2 2026
- Geode Capital Management 3.16M sh · $129.68M · Q2 2026
- Millennium Management 2.10M sh · $86.12M · Q2 2026
- Invesco Ltd 1.84M sh · $75.62M · Q2 2026
- Arrowstreet Capital 1.64M sh · $67.37M · Q2 2026
- Point72 Asset Management 1.25M sh · $51.31M · Q2 2026
- Northern Trust Corp 1.24M sh · $50.95M · Q2 2026
- Charles Schwab Investment Management 1.22M sh · $50.25M · Q2 2026
- Principal Global Investors 772.17K sh · $31.68M · Q2 2026